Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HGP0412 and HIP1402 in Benign Prostatic Hyperplasia
NCT02390882Phase 3Completed
- Sponsor
- Hanmi Pharmaceutical
- Start
- Oct 2014
- Primary completion
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tamsulosin in benign prostatic hyperplasia (BPH), sponsored by Hanmi Pharmaceutical. Started Oct 2014; status: completed.
02
Drugs
tamsulosin
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on NCT02390882.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02390882.